Ketone body β-hydroxybutyrate restores protein balance and targets Alzheimer’s-linked aggregates

Scientists identify β-hydroxybutyrate as a key regulator of protein solubility, offering a novel pathway to combat neurodegeneration in aging and Alzheimer’s disease.

Kinder, Gentler Regimen for Classical Hodgkin Prevails in Randomized Trial

CHICAGO — Replacing chemotherapy with a targeted agent resulted in a better tolerated regimen for advanced classical Hodgkin lymphoma (cHL) with no loss in efficacy,

June 2, 2024

Research provides insight into how the brain translates motivation into goal-oriented behavior

Hunger can drive a motivational state that leads an animal to a successful pursuit of a goal -; foraging for and finding food.

March 15, 2024

Ikena Oncology weighs ‘strategic options’ as it drops cancer asset, trims headcount to save cash

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

May 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.